- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05925400
Interest of Virtual Reality in the Management of Anxiety and Pain During Embryo Transfer (ET) (VR-INVENT)
Effect of Virtual Reality On IN-Vitro fEcuNdation ouTcomes: a Randomized Controlled Trial (VR-INVENT)
Study Overview
Status
Intervention / Treatment
Detailed Description
Medical interventions that they often cause pain, distress or anxiety for most patients.
The use of music and movies has been shown to be effective in pediatrics.
Actually, Virtual Reality (VR) is a recent technology that allows the representation of a pleasant environment in three dimensions with a complete immersion by a helmet. By distracting patients, this technology can reduce anxiety, discomfort and ultimately pain associated with care.
This randomized monocentric trial compares the effect of the use of VR vs without VR during blastocyst transfer at day 5 on the pregnancy rate and the level of anxiety and stress of the patient.
Data on the level of anxiety and stress will be collected via quiz before and after the procedure. Also, pregnancy rate will be assessed 10 days after the procedure by β_HCG assessment.
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Lee NGUYEN, MD
- Phone Number: 01 73 06 02 00
- Email: lee.nguyen@clinique-a-pare.fr
Study Locations
-
-
-
Neuilly-sur-Seine, France, 92200
- Recruiting
- Clinique Pierre Cherest
-
Contact:
- Nadia KAZDAR, MD
-
Principal Investigator:
- Nadia KAZDAR, MD
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Will benefit from in vitro Fertilization (IVF or ICSI)
- Aged over 18 and under 43,
- Attempt Rank 1 or 2
- To benefit from a transfer of a single fresh blastocyst on the 5th day of development
- Fresh embryo transfer
- Having received information and given their consent to participate in accordance with the regulations
- Benefiting from a social security scheme or entitled.
Exclusion Criteria:
- Use of frozen sperm
- Use of testicular sperm
- Fecundation technique used: IMSI
- Early embryo transfer on D2 or D3
- Inability to understand the information given
- Under guardianship, under curatorship or under safeguard of justice,
- Communication difficulties or neuropsychic disorders,
- Current corneal or conjunctival pathologies,
- Claustrophobia,
- Appearance of nausea in the mountains or at sea,
- Taking an anxiolytic or a sleeping pill within 12 hours prior to randomization
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
No Intervention: ET on D5 without RV
Patients who will be randomized to the control group will be waiting for the embryo transfer procedure according to the usual service protocol.
|
|
Experimental: ET on D5 with RV
The transfer and preparation in the transfer room will be done according to the usual service protocol. Exposure to virtual reality environment exposure |
Patients randomized to the study group, will be provided with the VR headset.
The VR exposure will take place 30 minutes before the Embryo Transfer (ET) and a 10 min immersion after the ET
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Clinical Pregnancy Rate
Time Frame: Assessed 4 weeks after embryo transfer
|
The rate of pregnancy , defined by a plasma beta-HCG dosage greater than 1000 UI , 10 days after the transfer, and sonographic evidence of a gestational sac on the echography of 6 weeks
|
Assessed 4 weeks after embryo transfer
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
State and Trait Anxiety Inventory (STAI) questionnaires
Time Frame: Questionnaires will be filled out in 2 different time points during the study: 1) ET day, 60 minutes before ET 2) ET day, 10 minutes after ET procedure
|
The rate of anxiety and stress level before and after embryo transfer, measured by the State and Trait Anxiety Inventory (STAI) StAI-Y1-State ranging from 20 to 80 (20 = Low Level of Anxiety), 80 = High Level Of Anxiety) StAI-Y2-Trait ranging from 20 to 80 (20 = Low Level of Anxiety), 80 = High Level Of Anxiety)
|
Questionnaires will be filled out in 2 different time points during the study: 1) ET day, 60 minutes before ET 2) ET day, 10 minutes after ET procedure
|
Beck Depression Index (C-BDI-II) questionnaires
Time Frame: Questionnaires will be filled out in 2 different time points during the study: 1) ET day, 60 minutes before ET 2) ET day, 10 minutes after ET procedure
|
The rate of anxiety and stress level before and after embryo transfer, measured by Beck Depression Index (C-BDI-II) questionnaires BDI-II ranging from 0 to 63 (0= No or Minimal Stress, 63= Worst Possible Stress)
|
Questionnaires will be filled out in 2 different time points during the study: 1) ET day, 60 minutes before ET 2) ET day, 10 minutes after ET procedure
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2022/02
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Stress
-
Massachusetts General HospitalCompletedStress | Emotional Stress | Psychological Stress | Social Stress | Life StressUnited States
-
University of PadovaRecruitingStress | Stress Disorder | Work Related StressItaly
-
University of California, Los AngelesUniversity of California, San Francisco; Stanford University; California Initiative...Enrolling by invitationStress | Stress, Psychological | Stress, Emotional | Stress, Physiological | Stress ReactionUnited States
-
Dana-Farber Cancer InstituteEnrolling by invitationStress | Post Traumatic Stress Disorder | Work Related StressUnited States
-
Duquesne UniversityUniversity of California, San Diego; West Penn Allegheny Health System; El Centro... and other collaboratorsTerminated
-
University of Sao PauloCompleted
-
Syracuse VA Medical CenterUS Department of Veterans AffairsCompletedEmotional Stress | Psychological Stress | Life StressUnited States
-
Royal Cornwall Hospitals TrustEnrolling by invitationStress | Stress, Psychological | Stress, JobUnited Kingdom
-
Northumbria UniversityVolac International LtdRecruitingStress | Mood | Physiological StressUnited Kingdom
-
Taichung Veterans General HospitalUnknown
Clinical Trials on Virtual Reality during Embryo Transfer
-
Hospices Civils de LyonRecruiting
-
University Hospital, AngersCompleted
-
Aretaieion University HospitalCompletedClinical Pregnancy Rate
-
Ruhr University of BochumCompletedPain | Anxiety | Cervical DysplasiaGermany
-
The University of Hong KongPeking University Third Hospital; Nanfang Hospital of Southern Medical University and other collaboratorsTerminated
-
Cairo UniversityRecruiting
-
Cardenal Herrera UniversityHospital de Manises; Universitat Politècnica de ValènciaCompletedEnd Stage Renal Disease | Hemodialysis-Induced SymptomSpain
-
University Hospital Virgen de las NievesInstituto de Salud Carlos IIICompletedInfertility | Pregnancy, MultipleSpain
-
Cardenal Herrera UniversityKarolinska Institutet; KU Leuven; Aristotle University Of Thessaloniki; University... and other collaboratorsRecruitingChronic Kidney Diseases | End Stage Renal Disease | Hemodialysis-Induced SymptomSpain, Belgium, Greece, Sweden
-
Stanford UniversityCompleted